Related references
Note: Only part of the references are listed.A review of HER2 overexpression and somatic mutations in cancers
Michael Galogre et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2023)
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study
John H Strickler et al.
LANCET ONCOLOGY (2023)
An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma
Silvia Mara Baez Rodriguez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Chronicles of EGFR Tyrosine Kinase Inhibitors: Targeting EGFR C797S Containing Triple Mutations
Krishna Babu Duggirala et al.
BIOMOLECULES & THERAPEUTICS (2022)
Inhibition of the endosomal recycling pathway downregulates HER2 activation and overcomes resistance to tyrosine kinase inhibitors in HER2-positive breast cancer
Anurag Mishra et al.
CANCER LETTERS (2022)
O-GlcNAcylation regulates epidermal growth factor receptor intracellular trafficking and signaling
Liming Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Plant ESCRT protein ALIX coordinates with retromer complex in regulating receptor-mediated sorting of soluble vacuolar proteins
Shuai Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Time-resolved proximity labeling of protein networks associated with ligand-activated EGFR
Mireia Perez Verdaguer et al.
CELL REPORTS (2022)
Mechanisms of neratinib resistance in HER2-mutant metastatic breast cancer
Lisa D. Eli et al.
CANCER DRUG RESISTANCE (2022)
Primaquine Inhibits the Endosomal Trafficking and Nuclear Localization of EGFR and Induces the Apoptosis of Breast Cancer Cells by Nuclear EGFR/Stat3-Mediated c-Myc Downregulation
Ji-Hyang Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The ER-embedded UBE2J1/RNF26 ubiquitylation complex exerts spatiotemporal control over the endolysosomal pathway
Tom Cremer et al.
CELL REPORTS (2021)
Clathrin-mediated EGFR endocytosis as a potential therapeutic strategy for overcoming primary resistance of EGFR TKI in wild-type EGFR non-small cell lung cancer
Boyeon Kim et al.
CANCER MEDICINE (2021)
Optimal Strategies for Successful Initiation of Neratinib in Patients with HER2-Positive Breast Cancer
Christian Jackisch et al.
CLINICAL BREAST CANCER (2021)
Endofin is required for HD-PTP and ESCRT-0 interdependent endosomal sorting of ubiquitinated transmembrane cargoes
Jalal M. Kazan et al.
ISCIENCE (2021)
UBTD1 regulates ceramide balance and endolysosomal positioning to coordinate EGFR signaling
Stephanie Torrino et al.
ELIFE (2021)
TIP30 overcomes gefitinib resistance by regulating cytoplasmic and nuclear EGFR signaling in non-small-cell lung cancer
Shuai Shuai et al.
CANCER SCIENCE (2021)
Mechanisms and management of 3rd-generation EGFR-TKI resistance in advanced non-small cell lung cancer (Review)
Jingyi He et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2021)
EGFR-RAS-MAPK signaling is confined to the plasma membrane and associated endorecycling protrusions
Sachin Surve et al.
JOURNAL OF CELL BIOLOGY (2021)
Imaging of Endocytic Trafficking and Extracellular Vesicles Released Under Neratinib Treatment in ERBB2+ Breast Cancer Cells
Sara Santamaria et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2021)
Phosphatidic acid-PKA signaling regulates p38 and ERK1/2 functions in ligand-independent EGFR endocytosis
Claudia Metz et al.
TRAFFIC (2021)
HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now
Ilana Schlam et al.
NPJ BREAST CANCER (2021)
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
S. S. Ramalingam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Four generations of EGFR TKIs associated with different pathogenic mutations in non-small cell lung carcinoma
Rui Li et al.
JOURNAL OF DRUG TARGETING (2020)
Primary Resistance to Brigatinib in a Patient with Lung Adenocarcinoma Harboring ALK G1202R Mutation and LIPI-NTRK1 Rearrangement
Zhiwei Xiao et al.
ONCOTARGETS AND THERAPY (2020)
Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy
Charles Pottier et al.
CANCERS (2020)
EGFR forms ligand-independent oligomers that are distinct from the active state
Patrick O. Byrne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Activated Protein Kinase C (PKC) Is Persistently Trafficked with Epidermal Growth Factor (EGF) Receptor
Carol A. Heckman et al.
BIOMOLECULES (2020)
Molecular Mechanism of HER2 Rapid Internalization and Redirected Trafficking Induced by Anti-HER2 Biparatopic Antibody
Jackie Cheng et al.
ANTIBODIES (2020)
Discovery of a novel EGFR ligand DPBA that degrades EGFR and suppresses EGFR-positive NSCLC growth
Nan Yao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Improving Receptor-Mediated Intracellular Access and Accumulation of Antibody Therapeutics-The Tale of HER2
Jeffrey Leyton
ANTIBODIES (2020)
Properties of FDA-approved small molecule protein kinase inhibitors
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2019)
SORLA regulates endosomal trafficking and oncogenic fitness of HER2
Mika Pietila et al.
NATURE COMMUNICATIONS (2019)
Molecularly Distinct Clathrin-Coated Pits Differentially Impact EGFR Fate and Signaling
Roberta Pascolutti et al.
CELL REPORTS (2019)
Intrinsic Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance
Eric Santoni-Rugiu et al.
CANCERS (2019)
Mathematical modeling of drug-induced receptor internalization in the HER2-positive SKBR3 breast cancer cell-line
Mirjam Fehling-Kaschek et al.
SCIENTIFIC REPORTS (2019)
Lipocalin-2 Regulates Epidermal Growth Factor Receptor Intracellular Trafficking
Lucie Yammine et al.
CELL REPORTS (2019)
Ligand-activated epidermal growth factor receptor (EGFR) signaling governs endocytic trafficking of unliganded receptor monomers by non-canonical phosphorylation
Tomohiro Tanaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors
D. Westover et al.
ANNALS OF ONCOLOGY (2018)
A cross-talk between integrin β4 and epidermal growth factor receptor induces gefitinib chemoresistance to gastric cancer
Jia Huafeng et al.
CANCER CELL INTERNATIONAL (2018)
Reactivation of Mutant-EGFR Degradation through Clathrin Inhibition Overcomes Resistance to EGFR Tyrosine Kinase Inhibitors
Ludovic Menard et al.
CANCER RESEARCH (2018)
High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)
Saranya Chumsri et al.
CLINICAL CANCER RESEARCH (2018)
HRS-WASH axis governs actin-mediated endosomal recycling and cell invasion
Ewan MacDonald et al.
JOURNAL OF CELL BIOLOGY (2018)
A secondary RET mutation in the activation loop conferring resistance to vandetanib
Takashi Nakaoku et al.
NATURE COMMUNICATIONS (2018)
Concerted ESCRT and clathrin recruitment waves define the timing and morphology of intraluminal vesicle formation
Eva Maria Wenzel et al.
NATURE COMMUNICATIONS (2018)
Phosphorylated EGFR Dimers Are Not Sufficient to Activate Ras
Samantha I. Liang et al.
CELL REPORTS (2018)
CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
Thanyanan Reungwetwattana et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Endosomal Retrieval of Cargo: Retromer Is Not Alone
Kerrie E. McNally et al.
TRENDS IN CELL BIOLOGY (2018)
Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer
Qianping Li et al.
JOURNAL OF THORACIC DISEASE (2018)
The EGFR odyssey - from activation to destruction in space and time
Jeroen Bakker et al.
JOURNAL OF CELL SCIENCE (2017)
Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial
Yi-Long Wu et al.
LANCET ONCOLOGY (2017)
Retriever is a multiprotein complex for retromer-independent endosomal cargo recycling
Kerrie E. McNally et al.
NATURE CELL BIOLOGY (2017)
Targeting EGFR T790M mutation in NSCLC: From biology to evaluation and treatment
Antonio Passaro et al.
PHARMACOLOGICAL RESEARCH (2017)
SNX-1 and RME-8 oppose the assembly of HGRS-1/ESCRT-0 degradative microdomains on endosomes
Anne Norris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Neuropilin-2 Regulates Endosome Maturation and EGFR Trafficking to Support Cancer Cell Pathobiology
Samikshan Dutta et al.
CANCER RESEARCH (2016)
Neratinib, A Novel HER2-Targeted Tyrosine Kinase Inhibitor
Shruti Rakesh Tiwari et al.
CLINICAL BREAST CANCER (2016)
FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer
Dickran Kazandjian et al.
CLINICAL CANCER RESEARCH (2016)
A combination of two antibodies recognizing non-overlapping epitopes of HER2 induces kinase activity-dependent internalization of HER2
Monika Szymanska et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial
Keunchil Park et al.
LANCET ONCOLOGY (2016)
Update to Rociletinib Data with the RECIST Confirmed Response Rate
Lecia V. Sequist et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Endocytosis separates EGF receptors from endogenous fluorescently labeled HRas and diminishes receptor signaling to MAP kinases in endosomes
Itziar Pinilla-Macua et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Clinical efficacy of first-generation EGFR-TKIs in patients with advanced non-small-cell lung cancer harboring EGFR exon 20 mutations
Dan Chen et al.
ONCOTARGETS AND THERAPY (2016)
EGFR oligomerization organizes kinase-active dimers into competent signalling platforms
Sarah R. Needham et al.
NATURE COMMUNICATIONS (2016)
A Structural Perspective on the Regulation of the Epidermal Growth Factor Receptor
Erika Kovacs et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 84 (2015)
Modulation of focal adhesion constituents and their down-stream events by EGF: On the cross-talk of integrins and growth factor receptors
Philipp Eberwein et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
ESCRT-0 marks an APPL1-independent transit route for EGFR between the cell surface and the EEA1-positive early endosome
Neftali Flores-Rodriguez et al.
JOURNAL OF CELL SCIENCE (2015)
Epidermal growth factor-stimulated Akt phosphorylation requires clathrin or ErbB2 but not receptor endocytosis
Camilo Garay et al.
MOLECULAR BIOLOGY OF THE CELL (2015)
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M
Kenneth S. Thress et al.
NATURE MEDICINE (2015)
EGF-dependent re-routing of vesicular recycling switches spontaneous phosphorylation suppression to EGFR signaling
Martin Baumdick et al.
ELIFE (2015)
Trafficking of Epidermal Growth Factor Receptor Ligands in Polarized Epithelial Cells
Bhuminder Singh et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 76 (2014)
Flotillin depletion affects ErbB protein levels in different human breast cancer cells
Nagham Asp et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
Live-cell fluorescence imaging reveals high stoichiometry of Grb2 binding to the EGF receptor sustained during endocytosis
Arola Fortian et al.
JOURNAL OF CELL SCIENCE (2014)
The level of HER2 expression is a predictor of antibody-HER2 trafficking behavior in cancer cells
Sripad Ram et al.
MABS (2014)
Acquired resistance to TKIs in solid tumours: learning from lung cancer
D. Ross Camidge et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Targeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells
D. Raina et al.
ONCOGENE (2014)
EGF receptor trafficking: consequences for signaling and cancer
Alejandra Tomas et al.
TRENDS IN CELL BIOLOGY (2014)
The EGFR Family: Not So Prototypical Receptor Tyrosine Kinases
Mark A. Lemmon et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Constitutive and ligand-induced EGFR signalling triggers distinct and mutually exclusive downstream signalling networks
Sharmistha Chakraborty et al.
NATURE COMMUNICATIONS (2014)
AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
Darren A. E. Cross et al.
CANCER DISCOVERY (2014)
EGFR endocytosis is a novel therapeutic target in lung cancer with wild-type EGFR
Ukhyun Jo et al.
ONCOTARGET (2014)
Membrane Interaction of Bound Ligands Contributes to the Negative Binding Cooperativity of the EGF Receptor
Anton Arkhipov et al.
PLOS COMPUTATIONAL BIOLOGY (2014)
The Mysterious Ways of ErbB2/HER2 Trafficking
Vibeke Bertelsen et al.
MEMBRANES (2014)
Architecture and Membrane Interactions of the EGF Receptor
Anton Arkhipov et al.
CELL (2013)
Conformational Coupling across the Plasma Membrane in Activation of the EGF Receptor
Nicholas F. Endres et al.
CELL (2013)
Vandetanib for the Treatment of Medullary Thyroid Cancer
Nicole G. Chau et al.
CLINICAL CANCER RESEARCH (2013)
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
Helena A. Yu et al.
CLINICAL CANCER RESEARCH (2013)
The HSP90 inhibitor geldanamycin perturbs endosomal structure and drives recycling ErbB2 and transferrin to modified MVBs/lysosomal compartments
Katia Cortese et al.
MOLECULAR BIOLOGY OF THE CELL (2013)
A global analysis of SNX27-retromer assembly and cargo specificity reveals a function in glucose and metal ion transport
Florian Steinberg et al.
NATURE CELL BIOLOGY (2013)
TIP30 loss enhances cytoplasmic and nuclear EGFR signaling and promotes lung adenocarcinogenesis in mice
A. Li et al.
ONCOGENE (2013)
Analysis of Conformational Determinants Underlying HSP90-Kinase Interaction
Rama Krishna Kancha et al.
PLOS ONE (2013)
HER2 shedding and serum HER2 extracellular domain: Biology and clinical utility in breast cancer
Chantal Tse et al.
CANCER TREATMENT REVIEWS (2012)
Oncogenic Mutations Counteract Intrinsic Disorder in the EGFR Kinase and Promote Receptor Dimerization
Yibing Shan et al.
CELL (2012)
Endosomal Accumulation of the Activated Epidermal Growth Factor Receptor (EGFR) Induces Apoptosis
Jamie S. Rush et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
p95HER2 Truncated Form in Resected Non-small Cell Lung Cancer
Federico Cappuzzo et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell et al.
LANCET ONCOLOGY (2012)
Lapatinib for Advanced or Metastatic Breast Cancer
Frans L. Opdam et al.
ONCOLOGIST (2012)
Correlation of HER2, p95HER2 and HER3 Expression and Treatment Outcome of Lapatinib plus Capecitabine in her2-Positive Metastatic Breast Cancer
Sae-Won Han et al.
PLOS ONE (2012)
Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membrane
Leiliane P. Sousa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Where EGF Receptors Transmit Their Signals
Nancy L. Lill et al.
SCIENCE SIGNALING (2012)
The Role of EGF Receptor Ubiquitination in Regulating Its Intracellular Traffic
Emily R. Eden et al.
TRAFFIC (2012)
Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells
Xiu-Rong Ren et al.
BREAST CANCER RESEARCH (2012)
Truncated HER2: implications for HER2-targeted therapeutics
Radoslaw Zagozdzon et al.
DRUG DISCOVERY TODAY (2011)
Vandetanib First Global Approval
Helen Commander et al.
DRUGS (2011)
Lipid Raft Localization of EGFR Alters the Response of Cancer Cells to the EGFR Tyrosine Kinase Inhibitor Gefitinib
Mary E. Irwin et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
EGFR and EGFRvIII undergo stress- and EGFR kinase inhibitor-induced mitochondrial translocalization: A potential mechanism of EGFR-driven antagonism of apoptosis
Xinyu Cao et al.
MOLECULAR CANCER (2011)
Mechanistic insights into the activation of oncogenic forms of EGF receptor
Zhihong Wang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
HER2-mediated upregulation of MMP-1 is involved in gastric cancer cell invasion
Wei Bao et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Quantitation of p95HER2 in Paraffin Sections by Using a p95-Specific Antibody and Correlation with Outcome in a Cohort of Trastuzumab-Treated Breast Cancer Patients
Jeff Sperinde et al.
CLINICAL CANCER RESEARCH (2010)
Multiple mechanisms collectively regulate clathrin-mediated endocytosis of the epidermal growth factor receptor
Lai Kuan Goh et al.
JOURNAL OF CELL BIOLOGY (2010)
Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer
David Jackman et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Spatial Structure of the Transmembrane Domain Heterodimer of ErbB1 and ErbB2 Receptor Tyrosine Kinases
Konstantin S. Mineev et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Structural Evidence for Loose Linkage between Ligand Binding and Kinase Activation in the Epidermal Growth Factor Receptor
Chafen Lu et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Nuclear trafficking of the epidermal growth factor receptor family membrane proteins
Y-N Wang et al.
ONCOGENE (2010)
Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src@
Byung Min Chung et al.
BMC CELL BIOLOGY (2009)
Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941
Teemu T. Junttila et al.
CANCER CELL (2009)
Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane Segment
Natalia Jura et al.
CELL (2009)
The EGFRvIII variant in glioblastoma multiforme
Hui K. Gan et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2009)
The Juxtamembrane Region of the EGF Receptor Functions as an Activation Domain
Monica Red Brewer et al.
MOLECULAR CELL (2009)
Structure-based view of epidermal growth factor receptor regulation
Kathryn M. Ferguson
ANNUAL REVIEW OF BIOPHYSICS (2008)
Functional and structural stability of the epidermal growth factor receptor in detergent micelles and phospholipid nanodiscs
Li-Zhi Mi et al.
BIOCHEMISTRY (2008)
A central role for HER3 in HER2-amplified breast cancer:: implications for targeted therapy
Si Tuen Lee-Hoeflich et al.
CANCER RESEARCH (2008)
Identification of the domain in ErbB2 that restricts ligand-induced degradation
Feng Shen et al.
CELLULAR SIGNALLING (2008)
c-Src trafficking and co-localization with the EGF receptor promotes EGF ligand-independent EGF receptor activation and signaling
Mrudula Donepudi et al.
CELLULAR SIGNALLING (2008)
Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer
Kirstine Roepstorff et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2008)
Geldanamycin-induced down-regulation of ErbB2 from the plasma membrane is clathrin dependent but proteasomal activity independent
Nina Marie Pedersen et al.
MOLECULAR CANCER RESEARCH (2008)
A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2
Katerina Sidera et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation
Kristina W. Thiel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Endocytic down-regulation of ErbB2 is stimulated by cleavage of its C-terminus
Mads Lerdrup et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer
Maurizio Scaltriti et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Characterization of a novel tripartite nuclear localization sequence in the EGFR family
Sheng-Chieh Hsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Controlled internalization of Her-2/neu receptors by cross-linking for targeted delivery
Wenlian Zhu et al.
CANCER BIOLOGY & THERAPY (2007)
EGFRvIII undergoes activation-dependent downregulation mediated by the Cbl proteins
G. C. Davies et al.
ONCOGENE (2006)
Flat clathrin coats on endosomes mediate degradative protein sorting by scaffolding Hrs in dynamic microdomains
Camilla Raiborg et al.
JOURNAL OF CELL SCIENCE (2006)
Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain
FT Huang et al.
MOLECULAR CELL (2006)
The inhibitory effect of ErbB2 on epidermal growth factor-induced formation of clathrin-coated pits correlates with retention of epidermal growth factor receptor-ErbB2 oligomeric complexes at the plasma membrane
C Haslekås et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Herceptin-induced inhibition of ErbB2 signaling involves reduced phosphorylation of Akt but not endocytic down-regulation of ErbB2
KE Longva et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Cholesterol dictates the freedom of EGF receptors and HER2 in the plane of the membrane
G Orr et al.
BIOPHYSICAL JOURNAL (2005)
Relationships between EGFR signaling-competent and endocytosis-competent membrane microdomains
C Puri et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Clathrin-independent endocytosis of ubiquitinated cargos
S Sigismund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: Implications for cancer immunotherapy
LM Friedman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex
WP Xu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Association with membrane protrusions makes ErbB2 an internalization-resistant receptor
AM Hommelgaard et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
MC Franklin et al.
CANCER CELL (2004)
Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin
CD Austin et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation
A Citri et al.
EMBO REPORTS (2004)
An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors
AW Burgess et al.
MOLECULAR CELL (2003)
Altered receptor trafficking in Huntingtin Interacting Protein 1-transformed cells
DS Rao et al.
CANCER CELL (2003)
Ligand-independent oncogenic signaling by the epidermal growth factor receptor: v-ErbB as a paradigm
JL Boerner et al.
EXPERIMENTAL CELL RESEARCH (2003)
The deaf and the dumb: the biology of ErbB-2 and ErbB-3
A Citri et al.
EXPERIMENTAL CELL RESEARCH (2003)
Grb2 regulates internalization of EGF receptors through clathrin-coated pits
XJ Jiang et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization
KM Ferguson et al.
MOLECULAR CELL (2003)
1,25-dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal growth factor receptor
JB Cordero et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains
H Ogiso et al.
CELL (2002)
Signal transduction and endocytosis: Close encounters of many kinds
A Sorkin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth
DB Agus et al.
CANCER CELL (2002)
Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking
P Burke et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
The role of distinct p185neu extracellular subdomains for dimerization with the epidermal growth factor (EGF) receptor and EGF-mediated signaling
T Kumagai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Share Paper
